Mangoceuticals Inc. (MGRX)
undefined
undefined%
At close: undefined
2.65
2.32%
After-hours Dec 13, 2024, 07:06 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -9.21M -2.00M -17.70K
Depreciation & Amortization 24.89K 3.86K -
Stock-Based Compensation 624.46K 234.09K -
Other Working Capital -65.58K -14.81K -
Other Non-Cash Items 1.52M 546.54K 181.00
Deferred Income Tax - -151.82K -
Change in Working Capital 41.51K 18.87K -
Operating Cash Flow -7.00M -1.35M -17.52K
Capital Expenditures -3.52K -43.10K -
Acquisitions - - -
Purchase of Investments - - -
Sales Maturities Of Investments - - -
Other Investing Acitivies - - -
Investing Cash Flow -3.52K -43.10K -
Debt Repayment -167.46K 49.93K -
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 1.02M - 160.28K
Financial Cash Flow 7.06M 2.05M 40.07K
Net Cash Flow 56.15K 660.31K 22.55K
Free Cash Flow -7.00M -1.39M -17.52K